Thursday, August 22, 2019

Recent Trends in Hematology/ Oncology


Research shows that combination of selinexor and dexamethasone induced responses among patients with refractory multiple myeloma. Explore more hemonc at: http://bit.ly/2xaW3zT
   


Posted by at
Labels: , , , , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)